A new era in infectious disease diagnostics

Delve Bio is on a mission to revolutionize infectious disease testing by bringing metagenomic (mNGS) testing out of the research lab and into the clinic. Founded by some of the world’s foremost experts in infectious disease, Delve Bio is ending the era of guess and test, enabling clinicians to test once and know.

icon-pioneers

Pioneers with purpose

At Delve, we are scaling our proprietary, ground-breaking metagenomic sequencing (mNGS) technology to give labs and clinicians the tool they need to move from “what’s wrong” to “what’s next.” Our team includes some of the most experienced and respected researchers, clinicians, investors and entrepreneurs in the world, working together to make mNGS diagnostics standard of care.

Meet the Delve Team

Brad Murray, MBA

Founder & CEO

Dr. Emily Crawford, PhD

Head of R&D

Andrew Carretta

Director of Software Engineering

Coren Milbury, PhD

VP of Product Development and Leadership

Steve Miller, MD, PhD

Chief Medical Officer

Jeff Field

Chief Commercial Officer

Amy Wong

Senior Director of Marketing and Business Development

Brian O’Donovan

Head of Bioinformatics

Michael Wilson, MD

Professor, University of California San Francisco
https://wilsonlab.ucsf.edu

Pardis Sabeti, MD, PhD

Professor, Harvard University
Institute Member, Broad Institute
https://www.sabetilab.org

Joe DeRisi, PhD

Professor, University of California San Francisco
President, Chan Zuckerberg Biohub
https://derisilab.ucsf.edu

Matthew Meyerson, MD, PhD

Director, Center for Cancer Genomics, Dana-Farber Cancer Institute
Professor of Genetics and Medicine, Harvard Medical School
Institute Member, Cancer Program, Broad Institute
https://meyersonlab.dana-farber.org

Charles Chiu, MD, PhD

Professor, Laboratory Medicine and Medicine / Infectious Diseases, University of California, San Francisco
Associate Director, UCSF Clinical Microbiology Laboratory
Investigator, Chan-Zuckerberg Biohub
https://chiulab.ucsf.edu

Brad Murray, MBA

Founder & CEO

Michael Wilson, MD

Professor, University of California San Francisco
https://wilsonlab.ucsf.edu

Mike Pellini

Mike Pellini, MD

General Partner, S32

Chris Garabedian

Chris Garabedian

Portfolio Manager, Venture, Perceptive Advisors

Jay Wohlgemuth

Jay Wohlgemuth, MD

Managing Partner, Trusted Health Advisors

Investors

Perceptive Xontogeny Venture Fund II

Section 32

Google Ventures

Working with leading hospitals

Leading institutions across the country use the power of metagenomics to deliver answers for their patients.